$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000139681422000021 Filed on February 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$159.2M	$541.5M	$131.0M
YoY Change	21.55%	26.04%	6.98%
Cost Of Revenue	$39.01M	$140.3M	$35.30M
YoY Change	10.51%	19.54%	10.64%
Gross Profit	$120.2M	$401.3M	$95.68M
YoY Change	25.62%	28.48%	5.7%
Gross Profit Margin	75.5%	74.1%	73.05%
Selling, General & Admin	$51.20M	$199.3M	$52.80M
YoY Change	-3.02%	3.01%	-2.58%
% of Gross Profit	42.6%	49.68%	55.19%
Research & Development	$15.51M	$55.55M	$15.30M
YoY Change	1.4%	-6.52%	-22.34%
% of Gross Profit	12.91%	13.84%	15.99%
Depreciation & Amortization	$13.07M	$28.55M	$5.060M
YoY Change	158.3%	43.4%	-0.59%
% of Gross Profit	10.87%	7.11%	5.29%
Operating Expenses	$74.37M	$254.9M	$70.10M
YoY Change	6.09%	0.77%	-41.93%
Operating Profit	$45.82M	$89.92M	$25.58M
YoY Change	79.14%	94.01%	-184.71%
Interest Expense	-$10.34M	$31.75M	-$6.400M
YoY Change	61.61%	23.68%	48.84%
% of Operating Profit	-22.57%	35.31%	-25.02%
Other Income/Expense, Net	-$66.00K	-$33.52M	$300.0K
YoY Change	-122.0%	27.64%	-133.33%
Pretax Income	-$6.198M	$56.40M	$12.70M
YoY Change	-148.8%	180.77%	-462.86%
Income Tax	-$1.068M	$14.40M	-$1.800M
% Of Pretax Income		25.53%	-14.17%
Net Earnings	-$5.130M	$41.98M	$14.51M
YoY Change	-135.35%	-71.15%	-396.93%
Net Earnings / Revenue	-3.22%	7.75%	11.08%
Basic Earnings Per Share		$0.95	$0.33
Diluted Earnings Per Share	-$115.0K	$0.92	$0.32
COMMON SHARES
Basic Shares Outstanding	44.54M shares	44.26M shares	43.44M shares
Diluted Shares Outstanding		45.63M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$656.4M	$656.4M	$521.7M
YoY Change	25.82%	25.82%	78.66%
Cash & Equivalents	$585.6M	$585.6M	$99.96M
Short-Term Investments	$70.83M	$70.83M	$421.7M
Other Short-Term Assets	$14.77M	$14.77M	$12.30M
YoY Change	20.09%	20.09%	13.89%
Inventory	$98.55M	$98.55M	$64.65M
Prepaid Expenses
Receivables	$96.32M	$96.32M	$53.05M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$866.0M	$866.0M	$651.6M
YoY Change	32.91%	32.91%	59.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$188.4M	$264.8M	$136.7M
YoY Change	37.83%	25.38%	30.58%
Goodwill	$145.2M		$99.55M
YoY Change	45.86%		0.0%
Intangibles	$624.0M		$96.52M
YoY Change	546.46%		-7.54%
Long-Term Investments	$21.99M	$21.99M	$109.5M
YoY Change	-79.92%	-79.92%	995.0%
Other Assets	$153.4M	$153.4M	$106.2M
YoY Change	44.41%	44.41%
Total Long-Term Assets	$1.209B	$1.209B	$622.9M
YoY Change	94.14%	94.14%	47.43%
TOTAL ASSETS
Total Short-Term Assets	$866.0M	$866.0M	$651.6M
Total Long-Term Assets	$1.209B	$1.209B	$622.9M
Total Assets	$2.075B	$2.075B	$1.275B
YoY Change	62.83%	62.84%	53.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.54M	$10.54M	$10.43M
YoY Change	1.07%	1.38%	-18.5%
Accrued Expenses	$127.6M	$126.5M	$70.97M
YoY Change	79.72%	66.0%	0.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$149.6M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$374.7M	$374.7M	$149.6M
YoY Change	150.47%	150.47%
Total Short-Term Liabilities	$521.1M	$521.1M	$253.3M
YoY Change	105.71%	105.73%	135.28%
LONG-TERM LIABILITIES
Long-Term Debt	$674.5M	$674.5M	$313.0M
YoY Change	115.5%	115.5%	2.29%
Other Long-Term Liabilities	$19.97M	$149.3M	$3.832M
YoY Change	421.19%	68.7%	155.13%
Total Long-Term Liabilities	$19.97M	$823.8M	$3.832M
YoY Change	421.19%	105.19%	155.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$521.1M	$521.1M	$253.3M
Total Long-Term Liabilities	$19.97M	$823.8M	$3.832M
Total Liabilities	$1.345B	$1.345B	$654.8M
YoY Change	105.39%	105.4%	37.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$211.9M		-$253.9M
YoY Change	-16.54%		-36.44%
Common Stock	$45.00K		$44.00K
YoY Change	2.27%		4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$730.4M	$730.4M	$619.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.075B	$2.075B	$1.275B
YoY Change	62.83%	62.84%	53.36%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$5.130M	$41.98M	$14.51M
YoY Change	-135.35%	-71.15%	-396.93%
Depreciation, Depletion And Amortization	$13.07M	$28.55M	$5.060M
YoY Change	158.3%	43.4%	-0.59%
Cash From Operating Activities	$23.22M	$125.7M	$46.66M
YoY Change	-50.25%	63.2%	80.15%
INVESTING ACTIVITIES
Capital Expenditures	-$9.166M	$45.87M	-$14.41M
YoY Change	-36.39%	21.34%	220.22%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$76.08M	$25.08M	-$67.91M
YoY Change	-212.04%	-110.46%	158.21%
Cash From Investing Activities	$66.92M	-$20.79M	-$82.32M
YoY Change	-181.29%	-92.51%	167.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	361.4M	$380.7M	10.36M
YoY Change	3388.5%	71.25%	-612.87%
NET CHANGE
Cash From Operating Activities	23.22M	$125.7M	46.66M
Cash From Investing Activities	66.92M	-$20.79M	-82.32M
Cash From Financing Activities	361.4M	$380.7M	10.36M
Net Change In Cash	451.5M	$485.6M	-25.30M
YoY Change	-1884.75%	2134.9%	265.61%
FREE CASH FLOW
Cash From Operating Activities	$23.22M	$125.7M	$46.66M
Capital Expenditures	-$9.166M	$45.87M	-$14.41M
Free Cash Flow	$32.38M	$79.85M	$61.07M
YoY Change	-46.98%	103.54%	100.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	USD
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-35060
CY2021	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	5401 West Kennedy Boulevard, Suite 890
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Tampa,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33609
CY2021	dei	City Area Code CityAreaCode	(813)
CY2021	dei	Local Phone Number LocalPhoneNumber	553-6680
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2021	dei	Trading Symbol TradingSymbol	PCRX
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1600000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44847728	shares
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	Short Hills, NJ
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	585578000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99957000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	70831000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	421705000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	96318000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53046000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	98550000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64650000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14771000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12265000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	866048000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	651623000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	95459000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	188401000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136688000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	76410000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74492000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	145175000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	623968000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	96521000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	153364000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	106164000	USD
CY2021Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	21987000	USD
CY2020Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	14019000	USD
CY2021Q4	us-gaap	Assets Assets	2075353000	USD
CY2020Q4	us-gaap	Assets Assets	1274513000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10543000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10431000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127555000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70974000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7891000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7425000	USD
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	350466000	USD
CY2020Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	149648000	USD
CY2021Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	0	USD
CY2020Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	14736000	USD
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	24234000	USD
CY2020Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	0	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	429000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	114000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	521118000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	253328000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	339267000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	313030000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71727000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71025000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10125000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	335263000	USD
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0	USD
CY2021Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	57598000	USD
CY2020Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	13610000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9847000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3832000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1344945000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	193516000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	654825000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44734308	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44734308	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43636929	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43636929	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	45000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	44000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	942091000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	873201000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-211895000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253875000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	167000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	318000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	730408000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2075353000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1274513000	USD
CY2021	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	125000	USD
CY2020	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	0	USD
CY2019	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	0	USD
CY2021	us-gaap	Revenues Revenues	541533000	USD
CY2020	us-gaap	Revenues Revenues	429647000	USD
CY2019	us-gaap	Revenues Revenues	421026000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	140255000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	117328000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	106712000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55545000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59421000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72119000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199345000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	200782000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13553000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7866000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5703000	USD
CY2021	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	42911000	USD
CY2020	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	5166000	USD
CY2019	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	25230000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	451609000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	383297000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	410546000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	89924000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	46350000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	10480000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	896000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	4629000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	7376000	USD
CY2021	us-gaap	Interest Expense InterestExpense	31750000	USD
CY2020	us-gaap	Interest Expense InterestExpense	25671000	USD
CY2019	us-gaap	Interest Expense InterestExpense	23628000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2666000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2852000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4976000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33520000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-26261000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21228000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	56404000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20089000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10748000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14424000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125434000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	41980000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.41
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.33
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44262000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42671000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41513000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45630000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43682000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41513000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	41980000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-180000	USD
CY2020	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-3000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	602000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	29000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-151000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	602000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	41829000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	145519000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10414000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8469000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2402000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33650000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	602000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	45229000	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2546000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39920000	USD
CY2020	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20450000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23834000	USD
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2811000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42246000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-151000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	41980000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	730408000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	41980000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10872000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126613000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1828000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28548000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19908000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19576000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2754000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2156000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1707000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	23152000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18254000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13746000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	10000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-22000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1010000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	42246000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	39920000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	33650000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-989000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	5204000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	16672000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2673000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	1618000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4315000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10434000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5516000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8524000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4467000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6353000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8026000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1142000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	739000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3885000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10262000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3312000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1822000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5451000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5999000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	22041000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-229000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2467000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6726000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	6835000	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	9409000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	370000	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	125000	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125717000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77032000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	70520000	USD
CY2021	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	420042000	USD
CY2020	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	117691000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45866000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37801000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10159000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	611488000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	546516000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	318484000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1068736000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	307870000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	319468000	USD
CY2021	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	4000000	USD
CY2020	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2019	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	9057000	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2019	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2021	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	17187000	USD
CY2020	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1160000	USD
CY2019	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1622000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20790000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-277607000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-128488000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23844000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	45218000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8469000	USD
CY2021	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2811000	USD
CY2020	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2546000	USD
CY2019	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2402000	USD
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	363750000	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2021	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	0	USD
CY2020	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	0	USD
CY2019	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	233000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4546000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	12487000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5165000	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5591000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6630000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	380694000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	222304000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3670000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	485621000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	21729000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54298000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99957000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	585578000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99957000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	6996000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7205000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	8199000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3221000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2417000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	863000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6828000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9288000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3019000	USD
CY2021	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	45241000	USD
CY2020	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
CY2019	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	28470000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, purchase price allocation, stock-based compensation, inventory costs, impairments of equity investments, long-lived assets, goodwill, liabilities and accruals, including contingent consideration, </span></div>convertible senior notes, and the valuation of deferred tax assets. The Company’s critical accounting policies are those that are both most important to the Company’s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	223000000	USD
CY2021Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	19000000	USD
CY2021Q4	us-gaap	Asset Backed Securities At Carrying Value AssetBackedSecuritiesAtCarryingValue	2600000	USD
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	51800000	USD
CY2020Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	6500000	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3300000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	26951000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	25447000	USD
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4804000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	28117000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	28123000	USD
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4798000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	41835000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	34203000	USD
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	12430000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	538966000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	426614000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418926000	USD
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	251762000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64650000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36337000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26886000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	35182000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16266000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	27031000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21498000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	98550000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	273641000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	215048000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	85240000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78360000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	188401000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136688000	USD
CY2021	us-gaap	Depreciation Depreciation	15000000	USD
CY2020	us-gaap	Depreciation Depreciation	12000000	USD
CY2019	us-gaap	Depreciation Depreciation	14000000	USD
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3900000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2400000	USD
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2400000	USD
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2000000	USD
CY2021Q4	pcrx	Number Of Locations New Operating Lease Liability NumberOfLocationsNewOperatingLeaseLiability	3	location
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	11976000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	10055000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	6225000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1722000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	2096000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1651000	USD
CY2021	us-gaap	Lease Cost LeaseCost	13698000	USD
CY2020	us-gaap	Lease Cost LeaseCost	12151000	USD
CY2019	us-gaap	Lease Cost LeaseCost	7876000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	12709000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	14347000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	7346000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8692000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	42191000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41605000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M7D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M4D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0696
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0687
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13171000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	13292000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13422000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	12561000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12296000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	39423000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	104165000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24547000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	79618000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2020	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	145175000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	590090000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27122000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	562968000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	651090000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27122000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	623968000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13569000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	96521000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13600000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7900000	USD
CY2021Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period1 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod1	57400000	USD
CY2021Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period3 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod3	57300000	USD
CY2021Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period2 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod2	57300000	USD
CY2021Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period4 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod4	36900000	USD
CY2021Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period5 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod5	7900000	USD
CY2021Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period6 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod6	2200000	USD
CY2021Q4	pcrx	Accruedsellinggeneralandadministrativeexpenses Accruedsellinggeneralandadministrativeexpenses	12063000	USD
CY2020Q4	pcrx	Accruedsellinggeneralandadministrativeexpenses Accruedsellinggeneralandadministrativeexpenses	23288000	USD
CY2021Q4	pcrx	Accruedresearchanddevelopmentexpenses Accruedresearchanddevelopmentexpenses	5480000	USD
CY2020Q4	pcrx	Accruedresearchanddevelopmentexpenses Accruedresearchanddevelopmentexpenses	6682000	USD
CY2021Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	14912000	USD
CY2020Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	11196000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	45491000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22202000	USD
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	35298000	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3040000	USD
CY2021Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	5358000	USD
CY2020Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2376000	USD
CY2021Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	8953000	USD
CY2020Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	2190000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127555000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70974000	USD
CY2021Q4	pcrx	Debt Instrument Prepayment Penalty Percent Year1 DebtInstrumentPrepaymentPenaltyPercentYear1	0.03
CY2021Q4	pcrx	Debt Instrument Prepayment Penalty Percent Year2 DebtInstrumentPrepaymentPenaltyPercentYear2	0.02
CY2021Q4	pcrx	Debt Instrument Prepayment Penalty Percent Year4 And Thereafter DebtInstrumentPrepaymentPenaltyPercentYear4AndThereafter	0.01
CY2021	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2021	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20500000	USD
CY2021	pcrx	Amortization Period Of Transaction Costs Attributable To Liability Component Of Convertible Debt AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt	P5Y
CY2021	pcrx	Transaction Costs Attributable To The Equity Component Of Convertible Debt TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt	2700000	USD
CY2017Q1	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9759000	USD
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7650000	USD
CY2019	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8195000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2754000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2156000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1707000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	23152000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18254000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13746000	USD
CY2021	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	3915000	USD
CY2020	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	2389000	USD
CY2019	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	20000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	31750000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	25671000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	23628000	USD
CY2021	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0666
CY2020	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0715
CY2019	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2021Q4	us-gaap	Share Price SharePrice	60.17
CY2021Q2	pcrx	Sharebased Compensation Arrangementby Sharebased Payment Award Increase In Numberof Shares Authorized SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseInNumberofSharesAuthorized	1500000	shares
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	70651000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	182000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	70831000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	516845000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	350000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	517164000	USD
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	100000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1600000	USD
CY2021	us-gaap	Equity Securities Fv Ni Realized Gain EquitySecuritiesFvNiRealizedGain	2600000	USD
CY2021	pcrx	Number Of Major Customers NumberOfMajorCustomers	4	customer
CY2020	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44734308	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44734308	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43636929	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43636929	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	pcrx	Employee Stock Purchase Plan Espp Sharesin Espp EmployeeStockPurchasePlanESPPSharesinESPP	500000	shares
CY2021Q4	pcrx	Maximum Fair Market Value Purchaseof Espp Shares MaximumFairMarketValuePurchaseofESPPShares	25000	USD
CY2021Q4	pcrx	Employee Stock Purchase Planfairvalue EmployeeStockPurchasePlanfairvalue	0.85
CY2021	pcrx	Stock Purchased And Issued During Period Shares Employee Stock Purchase Plans StockPurchasedAndIssuedDuringPeriodSharesEmployeeStockPurchasePlans	55483	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	14606701	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	12461531	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2145170	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42246000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39920000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33650000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42246000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39920000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33650000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8989000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8578000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	41980000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44262000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42671000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41513000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45630000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43682000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41513000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.41
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.33
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2270000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4352000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7044000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	64751000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7026000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-8348000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3089000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3722000	USD
CY2021	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	56403000	USD
CY2020	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	20089000	USD
CY2019	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-10748000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-6000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3533000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1185000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2096000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	19000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3552000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1179000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2096000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	12554000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-99164000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1828000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1682000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-27449000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10872000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126613000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1828000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14424000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125434000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14400000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125400000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0382
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0315
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0733
CY2021	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0115
CY2020	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	0.0318
CY2019	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0395
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0655
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6.4787
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1976
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0380
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0108
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.1053
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0300
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0792
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.1993
CY2021	pcrx	Effect Of State Blended Tax Rate Changes Expense Benefit EffectOfStateBlendedTaxRateChangesExpenseBenefit	0
CY2020	pcrx	Effect Of State Blended Tax Rate Changes Expense Benefit EffectOfStateBlendedTaxRateChangesExpenseBenefit	0
CY2019	pcrx	Effect Of State Blended Tax Rate Changes Expense Benefit EffectOfStateBlendedTaxRateChangesExpenseBenefit	-0.0042
CY2021	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0
CY2020	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	-0.0522
CY2019	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0513
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0455
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.1358
CY2021	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-0.0131
CY2020	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	0.0766
CY2019	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-0.1541
CY2021	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	0
CY2020	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	0
CY2019	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	-0.0961
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0167
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0184
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0235
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2557
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-6.2439
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0249
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2557
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-6.2439
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0249
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-126600000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-126600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	174203000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66123000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	35414000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	17335000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	80237000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	7254000	USD
CY2021Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	24545000	USD
CY2020Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	21862000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2430000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	572000	USD
CY2021	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.50
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1345000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2441000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2138000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	319842000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	116057000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	-131964000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	13473000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	15521000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	20851000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	147485000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7378000	USD
CY2021Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	172357000	USD
CY2020Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	108679000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18993000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2515000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	153364000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	106164000	USD
CY2021Q4	pcrx	Other Tax Attributes Subject To Limitation OtherTaxAttributesSubjectToLimitation	21200000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-16500000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-126600000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2900000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4300000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1400000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6076000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4300000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1355000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9021000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2800000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2600000	USD
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	200000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	200000	USD
CY2021	pcrx	Share Based Compensation Arrangement By Share Based Payment Award Performance Period ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod	P1Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent	1100000	USD
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	26371000	USD
CY2020	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	USD
CY2019	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	494000	USD
CY2021	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	40900000	USD
CY2019	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	150000	USD
CY2020	pcrx	Business Combination Acquisition And Integration Related Costs BusinessCombinationAcquisitionAndIntegrationRelatedCosts	4899000	USD
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	3500000	USD
CY2021Q4	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	42911000	USD
CY2020Q4	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	5166000	USD
CY2019Q4	pcrx	Acquisition Related Charges Product Discontinuation And Other AcquisitionRelatedChargesProductDiscontinuationAndOther	25230000	USD
CY2020	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	5300000	USD
CY2020	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
CY2019	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
CY2021	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
CY2019	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3500000	USD
CY2019Q1	pcrx	Litigation Investigation Term LitigationInvestigationTerm	P5Y
CY2019	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3500000	USD

Files In Submission

Name	View Source	Status
0001396814-22-000021-index-headers.html	Edgar Link	pending
0001396814-22-000021-index.html	Edgar Link	pending
0001396814-22-000021.txt	Edgar Link	pending
0001396814-22-000021-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_69a.jpg	Edgar Link	pending
image_71a.jpg	Edgar Link	pending
image_73a.jpg	Edgar Link	pending
image_75a.jpg	Edgar Link	pending
image_78a.jpg	Edgar Link	pending
image_80a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcrx-12312021xex103.htm	Edgar Link	pending
pcrx-12312021xex1036.htm	Edgar Link	pending
pcrx-12312021xex1037.htm	Edgar Link	pending
pcrx-12312021xex1038.htm	Edgar Link	pending
pcrx-12312021xex104.htm	Edgar Link	pending
pcrx-12312021xex211.htm	Edgar Link	pending
pcrx-12312021xex231.htm	Edgar Link	pending
pcrx-12312021xex311.htm	Edgar Link	pending
pcrx-12312021xex312.htm	Edgar Link	pending
pcrx-12312021xex321.htm	Edgar Link	pending
pcrx-12312021xex44.htm	Edgar Link	pending
pcrx-12312021xex45.htm	Edgar Link	pending
pcrx-20211231.htm	Edgar Link	pending
pcrx-20211231.xsd	Edgar Link	pending
pcrx-20211231_cal.xml	Edgar Link	unprocessable
pcrx-20211231_def.xml	Edgar Link	unprocessable
pcrx-20211231_g1.jpg	Edgar Link	pending
pcrx-20211231_g2.jpg	Edgar Link	pending
pcrx-20211231_g3.jpg	Edgar Link	pending
pcrx-20211231_htm.xml	Edgar Link	completed
pcrx-20211231_lab.xml	Edgar Link	unprocessable
pcrx-20211231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2021 Q4 Form 10-K Financial Statement

#000139681422000021 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2021 Q4 Form 10-K Financial Statement

#000139681422000021 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx